PRKDC and cancer: Notably, protein kinase, DNA-activated, catalytic subunit (PRKDC), and ubiquitin-specific protease 9X (USP9X) had higher mutation frequencies in multiple cancers, mainly including UCEC, SKCM, COAD, and STAD (Fig. 1C).